We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Accelerating Neuroscience-focused Ion Channel Drug Discovery

Product News   Dec 03, 2019

 
Accelerating Neuroscience-focused Ion Channel Drug Discovery
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Fujirebio Diagnostics Files 510(k) with FDA For Lumipulse G β-Amyloid Ratio

Product News

Fujirebio Diagnostics, Inc. today announced that it has filed its Lumipulse® G β-Amyloid Ratio (1-42/1-40) in vitro diagnostic test with the FDA.

READ MORE

MOBILion and International Research Team are Awarded Grant for Research in Parkinson's Disease

Product News

MOBILion Systems is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in the brain.

READ MORE

Abcam’s New Premium-Grade Bioactive Proteins, for Drug Discovery, Development and Manufacturing

Product News

Abcam’s new premium-grade proteins are manufactured in mammalian cell lines under animal-free conditions limiting endotoxins to ultra-low levels (< 5 EU/mg).

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE